TARIS Biomedical

edit

TARIS Biomedical a specialty pharmaceutical company with deep domain expertise in therapeutics and drug-delivery, is focused on local minimally-invasive drug-device convergence products. The TARIS core technology and development efforts are being applied to disease areas with high unmet medical need in which current therapies or systemic treatments have failed.

Milestones

edit

• Received $15M in Series A funding. (6/25/09)
  Posted 6/26/09 at 9:06pm

Videos

Screenshots

edit

Above: TARIS Biomedical
Uploaded: 6/27/09

Sources

1. Taris Biomedical raises $15 million (boston.bizjournals.com) [edit]